April 6th, 2023
Call to Order / Roll Call
Oral Communications
Agenda Changes, Additions, and Deletions
City Official Reports
2. Transmittal of 1) the ARB Meeting Schedule and Attendance Record, 2) Tentative Future Agenda items and 3) Recently Submitted Projects.
ACTION ITEMS
2. 3200 Park Boulevard/200 Portage/340 Portage [22PLN‐00287 and 22PLN‐00288]: Consideration of a Planned Community Zoning application to Allow Redevelopment of a 14.65‐acre site at 200‐404 Portage Avenue, 3040‐3250 Park Boulevard, 3201‐3225 Ash Street and 278 Lambert. The Scope of Work Includes the Partial Demolition of an Existing Commercial Building That has Been Deemed Eligible for the California Register as Well as an Existing Building With a Commercial Recreation use at 3040 Park and Construction of (74) new Townhome Condominiums, a Two‐Level Parking Garage, and Dedication of Approximately 3.25 acres of Land to the City for Future Affordable Housing and Parkland Uses. Existing R&D Uses Would Continue to Occupy the Remaining Cannery Building. The Existing Building at 3201‐3225 Ash Street Would Remain in Office use and an Automotive use at 3250 Park Boulevard Would Convert to R&D use. The Project also Includes a Development Agreement, Comprehensive Plan Amendment, and Vesting Tentative Map. Environmental Assessment: A Draft Environmental Impact Report for the 200 Portage Townhome Development Project was Circulated on September 16, 2022 in Accordance with the California Environmental Quality Act (CEQA). The EIR Comment Period Ended on November 15, 2022. The Proposed Development Agreement is Evaluated as Alternative 3 in the Draft EIR. Zoning District: RM‐30 (Multi‐Family Residential) and GM (General Manufacturing). For More Information Contact the Project Planner, Claire Raybould at Claire.Raybould@Cityofpaloalto.org.
3. Draft Architectural Review Board’s (ARB) Annual Report and Draft Work Plan
Approval of Minutes
4. Draft Architectural Review Board Meeting Minutes for March 2, 2023
Board Member Questions, Comments or Announcements
Adjournment
Ad Hoc Committee